23andMe: Joseph Arron

Joseph Arron has been appointed as CSO of 23andMe. Previously, he was VP and senior fellow of immunology research at Genentech, which he joined in 2006. In his new role, he will determine and prioritize 23andMe's therapeutic programs and indications, including drug discovery and target validation efforts. He will also lead the firm's scientific teams across multiple medical areas, including immuno-oncology, immunology, respiratory disease, and cardiovascular disease. Arron holds an MD/PhD from Cornell University Medical College and Rockefeller University and an undergraduate degree from Princeton University.